连续外周神经阻滞对截肢后幻肢痛与残肢痛的即时效应:多中心随机对照试验次要结局
多中心双盲随机对照试验纳入上下肢截肢且已存在幻肢痛的患者,行单次罗哌卡因外周神经阻滞并置管后,随机接受6天0.5%罗哌卡因或生理盐水连续输注。次要结局显示输注第1天局麻药组幻肢痛与残肢痛及疼痛干扰均低于安慰剂组,停药后第7至21天组间差异较少,至第28天差异恢复统计学显著。
要点
- 6天连续外周神经阻滞在输注期间可降低幻肢痛与残肢痛强度。
- 输注第1天疼痛对躯体与情绪功能的干扰在局麻药组更轻。
- 拔管后第7至21天组间差异较少,第28天差异恢复显著。
核心结论
- 次要分析提示连续外周神经阻滞在输注期间降低幻肢痛与残肢痛,但拔管后至第28天前少有改善被再次检出。
研究设计与样本
- 多中心随机对照试验的次要结局分析,5个招募中心参与。
- 纳入上下肢截肢且已存在幻肢痛的患者,先接受单次罗哌卡因外周神经阻滞并置入外周神经导管。
- 随后双盲随机接受6天门诊连续外周神经输注0.5%罗哌卡因或生理盐水。
- 输注开始后第1、7、14、21、28天电话随访,用数字评定量表测量疼痛。
- 各时间点用Wilcoxon秩和检验评估治疗效应,校正4个时间点后P<.0125为统计学显著。
主要发现
- 输注第1天幻肢痛强度局麻药组(n=71)中位数[四分位距]为0[0-2.5],安慰剂组(n=73)为3.3[0-5.0],中位差(98.75%CI)为-1.0(-3.0至0),P=.001。
- 输注第1天残肢痛强度局麻药组为0[0-0],安慰剂组为0[0-4.3],中位差(98.75%CI)为0.0(-2.0至0.0),P<.001。
- 输注第1天简明疼痛量表干扰域评分局麻药组为0[0-10],安慰剂组为10[0-40],中位差(98.75%CI)为0.0(-16.0至0.0),P=.002。
- 停输注后第7至21天,活性组与安慰剂组间仅发现少量差异。
- 两治疗组拔管后幻肢痛与残肢痛平均评分中位数总体逐渐升高,对照组至第28天升高更明显,此时组间差异恢复统计学显著。
临床怎么用
- 对已存在幻肢痛的截肢患者,围术期可考虑连续外周神经阻滞以在输注期间减轻幻肢痛与残肢痛。
- 应告知患者拔管后短期内疼痛可能回升,疗效差异可能需至拔管后约3周再次显现。
局限性
- 本文为次要结局分析,主要结局已在先前发表文章中报告。
- 第28天显著性沿用原已发表文章的方法报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We recently reported that a 6-day continuous peripheral nerve block reduced established postamputation phantom pain 3 weeks after treatment ended. However, the immediate effects of perineural infusion (secondary outcomes) have yet to be reported. METHODS: Participants from 5 enrolling academic centers with an upper or lower limb amputation and established phantom pain received a single-injection ropivacaine peripheral nerve block(s) and perineural catheter insertion(s). They were subsequently randomized to receive a 6-day ambulatory perineural infusion of either ropivacaine 0.5% or normal saline in a double-masked fashion. Participants were contacted by telephone 1, 7, 14, 21, and 28 days after the infusion started, with pain measured using the Numeric Rating Scale. Treatment effects were assessed using the Wilcoxon rank-sum test at each time point. Adjusting for 4 time points (days 1, 7, 14, and 21), P < .0125 was deemed statistically significant. Significance at 28 days was reported using methods from the original, previously published article. RESULTS: Pretreatment average phantom and residual pain scores were balanced between the groups. The day after infusion initiation (day 1), average phantom, and residual limb pain intensity was lower in patients receiving local anesthetic (n = 71) versus placebo (n = 73): median [quartiles] of 0 [0-2.5] vs 3.3 [0-5.0], median difference (98.75% confidence interval [CI]) of -1.0 (-3.0 to 0) for phantom pain (P = .001) and 0 [0-0] vs 0 [0-4.3], and median difference 0.0 (-2.0 to 0.0) for residual limb pain (P < .001). Pain's interference with physical and emotional functioning as measured with the interference domain of the Brief Pain Inventory improved during the infusion on day 1 for patients receiving local anesthetic versus placebo: 0 [0-10] vs 10 [0-40], median difference (98.75% CI) of 0.0 (-16.0 to 0.0), P = .002. Following infusion discontinuation (day 6), a few differences were found between the active and placebo treatment groups between days 7 and 21. In general, sample medians for average phantom and residual limb pain scores gradually increased after catheter removal for both treatments, but to a greater degree in the control group until day 28, at which time the differences between the groups returned to statistical significance. CONCLUSIONS: This secondary analysis suggests that a continuous peripheral nerve block decreases phantom and residual limb pain during the infusion, although few improvements were again detected until day 28, 3 weeks following catheter removal.
引用
- Ilfeld BM, Khatibi B, Maheshwari K, et al. Immediate Effects of a Continuous Peripheral Nerve Block on Postamputation Phantom and Residual Limb Pain: Secondary Outcomes From a Multicenter Randomized Controlled Clinical Trial. Anesth Analg. 2021. PMID: 34314392. doi:10.1213/ANE.0000000000005673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。